Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Retinal crystals in type 2 idiopathic macular telangiectasia.

Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UE, Dubra A, Williams DR, Clemons T, Pauleikhoff D, Bird AC, Peto T; MacTel Study Group.

Ophthalmology. 2011 Dec;118(12):2461-7. doi: 10.1016/j.ophtha.2011.05.022. Epub 2011 Aug 12.

2.

Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.

Chin EK, Kim DY, Hunter AA 3rd, Pilli S, Wilson M, Zawadzki RJ, Werner JS, Park SS.

Invest Ophthalmol Vis Sci. 2013 Jul 2;54(7):4459-70. doi: 10.1167/iovs.12-11116.

3.

High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.

Ooto S, Hangai M, Takayama K, Arakawa N, Tsujikawa A, Koizumi H, Oshima S, Yoshimura N.

Invest Ophthalmol Vis Sci. 2011 Jul 25;52(8):5541-50. doi: 10.1167/iovs.11-7251.

PMID:
21642620
4.

Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.

Chhablani J, Rao HB, Begum VU, Jonnadulla GB, Goud A, Barteselli G.

Invest Ophthalmol Vis Sci. 2015 Feb 5;56(2):1416-22. doi: 10.1167/iovs.14-15672.

PMID:
25655800
5.

Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.

Baumüller S, Charbel Issa P, Scholl HP, Schmitz-Valckenberg S, Holz FG.

Ophthalmology. 2010 Nov;117(11):2162-8. doi: 10.1016/j.ophtha.2010.02.014. Epub 2010 Jun 16.

PMID:
20557944
6.

Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.

Toto L, Di Antonio L, Mastropasqua R, Mattei PA, Carpineto P, Borrelli E, Rispoli M, Lumbroso B, Mastropasqua L.

Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT268-76. doi: 10.1167/iovs.15-18872.

PMID:
27409482
7.

Comparison of macular pigment in three types of macular telangiectasia.

Sawa M, Gomi F, Ueno C, Suzuki M, Nishida K.

Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):689-96. doi: 10.1007/s00417-012-2088-3. Epub 2012 Jul 12.

PMID:
22790309
8.

Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.

Oh JH, Oh J, Togloom A, Kim SW, Huh K.

Retina. 2014 Jun;34(6):1123-31. doi: 10.1097/IAE.0000000000000038.

PMID:
24240556
9.

Multimodal imaging in type 2 idiopathic macular telangiectasia.

Sallo FB, Leung I, Clemons TE, Peto T, Bird AC, Pauleikhoff D.

Retina. 2015 Apr;35(4):742-9. doi: 10.1097/IAE.0000000000000365.

PMID:
25412037
10.

Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.

Spaide RF, Klancnik JM Jr, Cooney MJ.

JAMA Ophthalmol. 2015 Jan;133(1):66-73. doi: 10.1001/jamaophthalmol.2014.3950.

PMID:
25317692
11.

"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia.

Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC; MacTel Study Group.

Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6145-52.

12.

"En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.

Wolff B, Basdekidou C, Vasseur V, Sahel JA, Gaudric A, Mauget-Faÿsse M.

Retina. 2014 Oct;34(10):2072-8. doi: 10.1097/IAE.0000000000000208.

PMID:
25255245
13.

Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.

Ooto S, Hangai M, Takayama K, Ueda-Arakawa N, Tsujikawa A, Yamashiro K, Oishi A, Hanebuchi M, Yoshimura N.

Am J Ophthalmol. 2013 Jun;155(6):1045-1057.e4. doi: 10.1016/j.ajo.2013.01.006. Epub 2013 Mar 7.

PMID:
23465268
14.

The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia.

Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC; MacTel Study Group.

Invest Ophthalmol Vis Sci. 2012 Nov 29;53(12):7889-95. doi: 10.1167/iovs.12-10765.

15.

Demographic features of idiopathic macular telangiectasia in Japanese patients.

Maruko I, Iida T, Sugano Y, Ojima A, Oyamada H, Sekiryu T.

Jpn J Ophthalmol. 2012 Mar;56(2):152-8. doi: 10.1007/s10384-011-0112-5. Epub 2012 Jan 6.

PMID:
22219035
16.

Demographic features of idiopathic macular telangiectasia in Korean patients.

Kim SH, Oh J, Ahn SE, Park CY, Oh JH.

Korean J Ophthalmol. 2015 Jun;29(3):155-9. doi: 10.3341/kjo.2015.29.3.155. Epub 2015 May 20.

17.

Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.

Chidambara L, Gadde SG, Yadav NK, Jayadev C, Bhanushali D, Appaji AM, Akkali M, Khurana A, Shetty R.

Br J Ophthalmol. 2016 Nov;100(11):1482-1488. doi: 10.1136/bjophthalmol-2015-307941. Epub 2016 Jan 28.

PMID:
26823394
18.

Prevalence and progression of pigment clumping associated with idiopathic macular telangiectasia type 2.

Meleth AD, Toy BC, Nigam D, Agrón E, Murphy RP, Chew EY, Wong WT.

Retina. 2013 Apr;33(4):762-70. doi: 10.1097/IAE.0b013e3182695bb3.

19.

CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.

Jacob J, Krivosic V, Paques M, Tadayoni R, Gaudric A.

Retina. 2016 Mar;36(3):545-51. doi: 10.1097/IAE.0000000000000737.

PMID:
26418443
20.

Perifoveal müller cell depletion in a case of macular telangiectasia type 2.

Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, Fruttiger M.

Ophthalmology. 2010 Dec;117(12):2407-16. doi: 10.1016/j.ophtha.2010.04.001. Epub 2010 Aug 3.

Supplemental Content

Support Center